Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To evaluate engraftment and toxicity of a reduced intensity preparative regimen for patients
who receive a matched related or unrelated donor allogeneic stem cell transplant (ASCT) for
malignant hematological diseases